News – Page 226 – Endpoints News

Beijing oncology biotech Avistone raises $140M Series B for commercialization in China, expansion into US

Last year

Another day, another ADC: OnCusp secures $100M Series A from Novo, OrbiMed and others to run PhI trial

Last year

AGC Biologics to build new government-funded $350M Japanese facility

Last year

Lyndra’s long-acting risperidone formulation hits PhIII schizophrenia trial endpoints

Last year

Virta Health, which got its start helping people manage diabetes with diet, launches weight loss program

Last year

ARCH-backed immunology company HI-Bio raises $95M as it pushes toward late-stage studies

Last year

Backed by CRISPR pioneer Feng Zhang, epigenetics biotech Moonwalk debuts with $57M

Last year

As the biotech funding game changed, TCGX altered course — and now they’re back with $1B for round two

Last year

Bayer and AskBio reveal early safety data for Parkinson's gene therapy, plot PhII study

Last year

Roche pens third pact of the week in $66M upfront to MOMA Therapeutics

Last year

What we’re doing differently at JP Morgan this year

Last year

Kymera doubles down on protein degraders for immunology, chasing Dupixent and Sotyktu

Last year

Exclusive: After Turning Point success, oncology vets in-license first asset for Avenzo Therapeutics

Last year

Novo’s broad Flagship partnership starts with obesity at Omega and MASH at Cellarity

Last year

Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug

Last year

All the new drugs approved in 2023: Alzheimer's and gene therapy cap a five-year high

Last year

Dr. Reddy's, Torrent Pharma and Laurus Synthesis all land Form 483 letters following FDA inspections

Last year

Where are the adcomms? FDA has scheduled no drug or biologic meetings for 2024 so far

Last year

Bausch + Lomb puts new spin on annual glaucoma campaign with a focus on ‘Faces’

Last year

GSK shrinks Scynexis deal after delay in commercialization of antifungal drug

Last year

Pfizer gene therapy gets hemophilia B approval in Canada, setting stage for CSL rivalry

Last year

Daiichi Sankyo settles its cardio drug lawsuit with Esperion, which will get $125M milestone payment

Last year

Updated: FDA says it has no plans for Israel-based office

Last year

Biden administration to use Defense Production Act to tackle drug shortages

Last year

First page Previous page 223 224 225226227 228 229 Next page Last page